Abeona Therapeutics
ABEO
73 hedge funds and large institutions have $50.8M invested in Abeona Therapeutics in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 18 closing their positions.
418% more call options, than puts
Call options by funds: $114K | Put options by funds: $22K
123% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 13
44% more capital invested
Capital invested by funds: $35.3M → $50.8M (+$15.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.38% less ownership
Funds ownership: 1.7% → 1.32% (-0.38%)
6% less funds holding
Funds holding: 78 → 73 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.52M |
| 3 |
Renaissance Technologies
New York
|
+$1.56M |
| 4 |
State Street
Boston,
Massachusetts
|
+$337K |
| 5 |
JP Morgan Chase
New York
|
+$296K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.97M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.73M |
| 3 |
Millennium Management
New York
|
-$1.55M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.1M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$944K |
ABEO Hedge Fund Activity: Q4 2020 in Review
73 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2020, worth a combined $50.8M — up 44% from $35.3M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of ABEO and 13 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 29 added.
The largest buyer was Adage Capital Partners, adding an estimated $3.8M. The largest seller was Great Point Partners, exiting entirely with an estimated $3.97M sold.
- 73 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2020, down from 78 in Q3 2020.
- Funds reported $50.8M of Abeona Therapeutics stock for Q4 2020, up 44% quarter-over-quarter.
- 13 funds opened new Abeona Therapeutics positions in Q4 2020 and 18 closed out, a net change of -5 holders.
- The largest Abeona Therapeutics buyer in Q4 2020 was Adage Capital Partners, an estimated $3.8M added.
- The largest Abeona Therapeutics seller in Q4 2020 was Great Point Partners, an estimated $3.97M sold.
Based on aggregated 13F filings for Q4 2020.